abstract |
There are provided spiroindolinone derivatives of the formula (I) and pharmaceutically acceptable salts and esters thereof, wherein X, R1, R2, R3, R4 and R are as herein described. The compounds of the present invention are useful in the treatment or control of cell proliferative disorders, in particular oncological disorders. |